Scholars Central

Case reportPublished 28 Jun 2024

Use of an Anti-CD6 Antibody (Itolizumab) for the Treatment of COVID-19 Patients with Cytokine Release Syndrome Report of Three Cases

Authors: Lazaro Manuel Filgueira, Julio Betancourt Cervantes, Orlando Adolfo Lovelle, Carlos Herrera, Carlos Figueredo, Jorge Alain Caballero, Naivy Sanchez, Jorge Berrio, Geidy Lorenzo, Meylan Cepeda, Mayra Ramos, Danay Saavedra, Ana Laura Ane-Kouri, Zaima Mazorra, Kalet Leon, Tania Crombet, Armando Caballero

Immunotherapy: Open Access

Volume 10 · Issue 3 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A group of COVID-19 patients develops severe or critical disease accompanied by the cytokine storm syndrome. Cytokines are essential to the pathophysiology of disease and Interleukin 6 (IL-6), Interleukin 1 (IL-1) and Tumor Necrosis Factor Alpha (TNF-α) appear to be harmful, particularly in the context of the cytokine release syndrome. CD6 is a membrane glycoprotein expressed primarily in mature, activated T-cells. Ligand binding of CD6, increases events such as adhesion, activation, proliferation, differentiation and survival. In addition, CD6 mediates interaction between T-cells and antigen-presenting cells, contributing to the maturation of immune synapses. CD6-mediated costimulation contributes to the maturation of a Th1 pattern in human T-cells and preferentially promotes a proinflammatory response characterized by the secretion of TNF-α, IL-6 and interferon.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Immunotherapy: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalImmunotherapy: Open Access
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Lazaro Manuel Filgueira”
  • BylineArticles whose byline prints “Julio Betancourt Cervantes”
  • BylineArticles whose byline prints “Orlando Adolfo Lovelle”
  • BylineArticles whose byline prints “Carlos Herrera”
  • BylineArticles whose byline prints “Carlos Figueredo”
  • BylineArticles whose byline prints “Jorge Alain Caballero”
  • BylineArticles whose byline prints “Naivy Sanchez”
  • BylineArticles whose byline prints “Jorge Berrio”